Filed: 2026-04-16 AccNo: 0001628280-26-025508 Size: 558 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
NS
Spyre Therapeutics, Inc.company
Entity Detail
Signal Strength0.19
相关文章4
提及次数4
平均情绪+0.01
平均重要度64
时间序列
用日级聚合看该实体在什么时间点成为主要新闻焦点。
最新活跃 04/16 / 2 个活跃日
01/2804/27
峰值强度1.81
最新活跃提及1
最新活跃情绪+0.02
最新原文时间04/16 20:15
相关文章
从实体聚合视角回到具体文章。
4 篇
Filed: 2026-04-13 AccNo: 0001628280-26-024940 Size: 522 KB
Filed: 2026-04-13 AccNo: 0001628280-26-024906 Size: 155 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events
Filed: 2026-04-13 AccNo: 0001628280-26-024831 Size: 4 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits